Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer (clinicaltrials.gov) - Oct 3, 2026 - P=N/A | N=370 | Recruiting | Sponsor: Fundación Santa Fe de Bogota
New trial • Breast Cancer • HER2 Breast Cancer • HER2 Positive Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer
|